C000059046 Fees and Costs — Target 2020 Series, Class R

Data updated: 2020-09-25

The net expense ratio is 1.20% (1.37% before fee waivers). There are no sales loads or redemption fees. Portfolio turnover was 17%.

C000059046 Fees and Expenses

Annual operating expenses and sales charges of C000059046. Prospectus, as of February 29, 2020.

Annual operating expenses
Management fee0.00%
12b-1 fee0.50%
Other expenses0.37%
Gross expense ratio1.37%
Fee waiver−0.17%
Net expense ratio1.20%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

C000059046 Costs Over Time

On $10,000 invested in C000059046, assuming 5% a year before costs, total costs come to $748 over 5 years, cutting the return by 1.26% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.20%)$126$392$679
Lost growth on money paid in costs$0$19$69
Total costs$126$412$748
Value after costs$10,374$11,164$12,015
Impact on return, per year1.26%1.26%1.26%

C000059046 Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2019.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $63.2M
  • Portfolio turnover (prospectus): 17%
  • Securities lending: none during the year

C000059046 Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
Manning & Napier Fund Inc.Blended Asset Moderate Series Class R6$55.4M87.69%
Manning & Napier Fund Inc. - Blended Asset Extended Series Class R6$7.8M12.31%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.